A screening tool developed with artificial intelligence and trained on hundreds of hours of patient interviews could flag risks for relapse in liver transplant patients with alcohol use disorder — and prompt precise interventions, according to a new study from the Keck School of Medicine of USC.

“We know that alcohol use disorder is a chronic disease,” said Brian Lee, MD, PhD, the study’s lead author and a transplant hepatologist at Keck Medicine of USC. “A liver transplant will cure their liver disease but it won’t necessarily cure their alcohol use disorder. A better understanding of their risk of relapse after transplant helps us tailor treatments. There’s an urgency for more tools.”

To continue reading this story, click here.